MON-265 Once-Weekly Somapacitan in Japanese Adults with GH Deficiency Was Well Tolerated, with Similar Efficacy to Daily GH: A Randomized Trial

Somapacitan is a long-acting, reversible albumin-binding human growth hormone (GH) derivative based on a proven protraction technology. The objective of this trial was to evaluate the safety, efficacy and treatment satisfaction of once-weekly somapacitan compared with daily GH (Norditropin®) over 52...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Endocr Soc
Huvudupphovsmän: Otsuka, Fumio, Takahashi, Yutaka, Tahara, Shigeyuki, Rasmussen, Michael Højby, Ogawa, Yoshihisa, Takano, Koji
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2020
Ämnen:
Neuroendocrinology and Pituitary
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7209108/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.605
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk